New tests launched in November - Insights
Mayo Clinic Laboratories launched the following three tests in November.
Chromium and Cobalt Testing [Test in Focus] - Insights
Chromium and cobalt blood tests are used to monitor exposure to these elements. Both of these elements are naturally occurring and widely distributed in the environment. Previously, serum samples were collected and used to monitor patients...
Alpha-gal testing [Test in Focus] - Insights
Joshua Bornhorst, Ph.D., associate director of Mayo Clinic's Clinical Immunoassay Lab, explains how humans can develop an allergy to the alpha-gal molecule, and he describes a new allergen antibody test that can be used to detect it. Dr....
Case Studies in Laboratory Safety - Insights
PACEThis webinar will provide a review of several real-life laboratory safety events. The presentation will outline the scenarios, the lessons learned and look at ways future incidents can be prevented. We will also discuss ways to create...
Find out how patients with a cancer diagnosis can benefit from single-gene analysis to pinpoint whether the cancer is genetic in nature.
Labor Day Holiday Shipment Schedules - Insights
Due to the Labor Day holiday (recognized on Monday, September 4th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen viability and avoid turnaround time delays, follow the guidelines...
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...
Christmas and New Year's specimen shipment alert - Insights
Due to the Christmas and New Year's holiday's (recognized on Saturday, December 25th, and Saturday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and...
MCL Hereditary Peripheral Neuropathy Flyer MC2775648
MCL Hereditary Peripheral Neuropathy Flyer HEREDITARY PERIPHERAL NEUROPATHY SIMPLIFY IMPROVE DIAGNOSIS PHENOTYPIC FOCUSED TESTING Hereditary peripheral neuropathies diverse group disorders
July 2023 - Clinical Microbiology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
Mayo Clinic Laboratories offers a robust menu of biomarker testing to assess liver disease related to nonalcoholic and alcoholic causes. These include FibroTest-ActiTest, a first-line screening assay that uses two diagnostic scores based on...
Dementia with Lewy bodies, Parkinson's, and multiple system atrophy - Insights
Learn more about how Mayo Clinic Laboratories' cerebrospinal fluid biomarker test for synucleinopathies, such as Parkinson’s disease and dementia with Lewy bodies, can accurately identify α-syn pathology even before definitive symptoms...
Membranous nephropathy assay: PMND1 - Insights
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a...
meningitis-encephalitis_panel_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 01/2024 Recommended testing for patients with findings suggestive of acute (<8 days of symptoms) meningitis or encephalitis. NOTE: Not intended for patients...
meningitis-encephalitis_panel_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 11/2024 Recommended testing for patients with findings suggestive of acute (<8 days of symptoms) meningitis or encephalitis. NOTE: Not intended for patients...
CPT codes and LOINC update: December 2022 - Insights
This page includes updates posted to the site during the month of December.
Mayo Clinic Laboratory and pathology research roundup: March 22 - Insights
This Feature Includes: A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 13 - Insights
This week’s Research Roundup highlights diagnostic thresholds for androgen-producing tumors or pathologic hyperandrogenism in women by use of total testosterone concentrations measured by liquid chromatography-mass spectrometry.
Week in Review: May 27 - Insights
Today's highlights include: Long COVID affects more older adults, US has a new dominant COVID-19 strain, and Gianrico Farrugia explains how we can transform healthcare by moving from pipeline to platform.
Growing Your Laboratory Through Outreach - Insights
Providing resources on how to best leverage and optimize your laboratory for patients, clients, and staff.
July 2023 - Dermatopathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Dermatopathology.
Malabsorption disorders - Insights
Malabsorption syndrome encompasses several disorders that impact the ability of the small intestine to absorb macronutrients, micronutrients, or both. Because malabsorption syndrome can be caused by myriad factors, identifying the...
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...
New tests launched in July - Insights
In July 2022, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Rapid hereditary breast cancer - Insights
Learn how our rapid breast cancer treatment panel delivers results in 10 to 14 days and detects 11 genes linked to lifetime breast cancer risk.
Learn more about how Mayo Clinic Laboratories’ genetic testing for pancreatic disease can provide a clearer understanding of a patient’s condition.
Heparin Induced Thrombocytopenia (HIT) and the Role of Serotonin Release Assay (SRA) - Insights
In this month's "Hot Topic," Rajiv Pruthi, M.B.B.S., discusses heparin induced thrombocytopenia (HIT), approach diagnosis, and the role of the functional serotonin release assay (SRA).
Error - Mayo Clinic Laboratories
Share Print Web: mayocliniclabs.com...
MayoLINK Overview Video - Mayo Clinic Laboratories
MayoLINK Overview Video - Mayo Clinic Laboratories Share Print...
Alzheimer's Disease CSF Biomarkers - Insights
In this month's "Hot Topic," Alicia Algeciras, Ph.D., DABCC, and Joshua Bornhorst, Ph.D., DABCC, discuss Alzheimer's disease CSF biomarkers.
The Prostate Health Index (PHI) in Prostate Cancer Risk Assessment - Insights
In this month’s “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., will provide you with valuable information regarding the utility of the prostate specific antigen test, and how the calculation of a prostate health index, or phi, can help to...
Mayo Clinic Labs @Work: Daniel Kronemann - Insights
As a clinical laboratory technologist, Daniel Kronemann enjoys going beyond his day-to-day work as he explores new ways to enhance processes and systems in Bacteriology.
Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.
New tests launched in August - Insights
In August 2022, Mayo Clinic Laboratories announced thirty-two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
PathWays Case Studies: Nov. 2018 - Insights
Mayo Clinic laboratory experts share three case studies in this month’s “PathWays” post and are challenging you to test your Clinical Pathology, Molecular Diagnostic, Hematopathology, and Dermatology pathology knowledge. Review the cases,...
CPT Codes and LOINC Updates Archives - Page 5 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Week in Review: October 18 - Insights
Top highlights include: scientists continue to investigate mysterious vaping illnesses, a possible vaccine for breast cancer could be available in less than a decade, and determining if patients are sick from the flu or from vaping.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 20 - Insights
This week’s Research Roundup highlights how fasting blood glucose levels provide an estimate of duration and progression of pancreatic cancer before diagnosis.
Pathways Case Studies: November 2019 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for November include the following sub-specialties: Cytogenetics, Genetics,...
December 2022 - Transfusion Medicine - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Transfusion Medicine.
Activity Metrics Dashboard - Insights
We are excited to share that the Activity Metrics Dashboard is now live on mayocliniclabs.com. We heard your feedback and created these reports to provide a more integrated, intuitive and customized experience on our website.
Monogenic IBD Testing - Mayo Clinic Laboratories
Monogenic inflammatory bowel disease (IBD) refers to a diverse spectrum of rare genetic disorders that present with intestinal inflammation. The majority of patients with monogenic IBD, unlike those with polygenic IBD, show symptoms before...
Liquid biopsy cancer testing - Insights
Learn how the pioneering approach used in liquid biopsy testing available through Mayo Clinic Laboratories enables individualized insights that drive personalized care.
Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.
Top 5 Mayo Clinic Laboratories advancements in 2024 - Insights
Five of the most significant advancements from Mayo Clinic Laboratories in 2024 to enhance diagnostics and patient care globally.
MayoLINK Universal Test Management Solution - Mayo Clinic Laboratories
MayoLINK Universal Test Management Solution - Mayo Clinic Laboratories Share Print...
MCL Neuromuscular Flyer MC2775647
MCL Neuromuscular Flyer HEREDITARY NEUROMUSCULAR DISORDERS ENHANCE DIAGNOSIS PHENOTYPIC DIRECTED TESTING emergence advanced molecular testing technologies improved detection
Units of Measurement - Mayo Clinic Laboratories
Units of Measure A list of common units used in the reporting of our assays has been defined. Refer to the table for these units as well as the recommended report abbreviations. Last updated: June 6, 2025...
Prenatal - Mayo Clinic Laboratories
Share Print Web: mayocliniclabs.com...
Testing Archives - Page 16 of 25 - Insights
Skip to Content MayoACCESS MayoLINK...